Windtree Appoints Dr. Joseph Soffer to Lead Cardiovascular Clinical Development
Share this article Share this article WARRINGTON, Pa., Feb. 1, 2021 /PRNewswire/ -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced the appointment of Joseph Soffer, M.D., F.A.C.C., as Executive Director of Clinical Development, effective immediately. "We are thrilled to welcome Joe to lead our cardiovascular clinical development efforts at such an important time for Windtree," said Dr. Steve Simonson, Chief Medical Officer at Win...
Source: prnewswire.com